<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:contributor>G. Maestrone</dc:contributor>
  <dc:contributor>C. Starliper</dc:contributor>
  <dc:contributor>B. Schill</dc:contributor>
  <dc:creator>G. L. Bullock</dc:creator>
  <dc:date>1983</dc:date>
  <dc:description>&lt;p&gt;&lt;span&gt;In 8 of 10 field trials, treatment with a potentiated sulfonamide, Ro5‐0037 (5 parts sulfadimethoxine and 1 part ormetoprim) at 50 mg/kg of fish per day for 5 days provided control of furunculosis.&lt;/span&gt;&lt;/p&gt;</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>10.1577/1548-8659(1983)45[51:F]2.0.CO;2</dc:identifier>
  <dc:language>en</dc:language>
  <dc:publisher>Oxford Academic</dc:publisher>
  <dc:title>Furunculosis: Results of field trials for therapy with Ro5-0037, a potentiated sulfonamide</dc:title>
  <dc:type>article</dc:type>
</oai_dc:dc>